#USA #New York #Securities Law #Semler Scientific #Faruqi & Faruqi

Faruqi & Faruqi, LLP Investigates Semler Scientific Claims

Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into allegations on behalf of investors affected by Semler Scientific, Inc. This investigation focuses on potential claims resulting from significant financial losses exceeding $75,000 incurred between March 10, 2021, and April 15, 2025. The investigation comes at a crucial time when the firm is notifying affected investors to contact them for a deeper discussion about their legal rights and options.

Background on Semler Scientific

Semler Scientific, listed under NASDAQ SMLR, has faced scrutiny over its disclosures related to a material investigation conducted by the U.S. Department of Justice (DOJ) regarding the violations of the False Claims Act. This inquiry raises serious concerns regarding the transparency and accuracy of the company's public communications, particularly around the time it announced its 2024 annual report on February 28, 2025.

It was during this crucial reporting period that Semler Scientific reportedly began preliminary settlement discussions with the DOJ. However, those discussions abruptly ceased, leading to concerns that the DOJ might escalate its actions, potentially filing a complaint and intervening in a civil lawsuit regarding the company's alleged dealings. Importantly, Semler Scientific noted that they could not reasonably estimate the financial implications of these investigations, impacting investor confidence and stock performance significantly. After the news broke on February 28, Semler's stock experienced a notable decline of over 9% during the subsequent trading session.

Legal Implications for Investors

The legal framework governing these allegations is grounded in federal securities laws, which serve to protect investors against misleading statements and failures to disclose critical information. Faruqi & Faruqi highlights that any member of the putative class who has suffered loss may move to take on the role of lead plaintiff in the evolving class action lawsuit. This position involves not only directing the litigation but also representing the collective interests of the affected investor cohort.

The firm emphasizes that it is essential for affected investors to engage with them proactively, sharing relevant information and experiences to bolster the investigation. This offers investors who may have been unaware of their rights a chance to reclaim some of their losses. Whistleblowers, past employees, and shareholders are particularly encouraged to share insights that could aid the case.

How to Respond

For those who believe they might be eligible, Faruqi & Faruqi provides accessible channels for reaching out. Investors who experienced financial losses and wish to explore their legal options are urged to contact Josh Wilson, a senior partner at the firm. With direct lines available for inquiry, Wilson is prepared to discuss individual cases in detail. Interested individuals can reach him at 877-247-4292 or 212-983-9330 (Ext. 1310).

To further support investors in understanding this situation, the firm has set up an informative web page dedicated to the Semler Scientific class action, allowing potential claims to be filed and inquiries to be made. With the deadline for filing as lead plaintiff looming, Faruqi & Faruqi acts as a vital resource for navigating this complex legal landscape. Through their expertise, they aim to assist investors in achieving fair recourse in light of these challenging circumstances.

As this situation develops, it is crucial for affected Semler Scientific investors to remain informed and engaged. Following developments via platforms such as LinkedIn, X, or Facebook can provide ongoing insights into this case and broader implications within the market. Investors are reminded that prior results do not guarantee similar outcomes in the future. Each case is distinct and requires careful consideration.